XOMAP Q1 2019 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+1656.2% YoY

Gross Profit

$8M96.9% margin

Operating Income

$2M23.8% margin

Net Income

$3M39.8% margin

EPS (Diluted)

$0.29

QoQ Revenue Growth

+382.6%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$76M

Total Liabilities

$52M

Stockholders' Equity

$24M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$463,000	+1656.2%
Gross Profit	$8M	$31,000	+25303.2%
Operating Income	$2M	-$5M	+137.7%
Net Income	$3M	-$4M	+184.9%